Clear ×
Lantheus Holdings, Inc. LNTH

Showing 10-K, 10-Q & 8-K from the last 6 months. Need full history or all form types?

Oct 22, 2026 8-K 1 signal fired
Other
Merger Proxy Statement Disclosure
Oct 2, 2026 8-K 3 signals fired
Other
Merger Proxy Statement Disclosure Stock Option Grant Disclosed Acquisition And Management Fees Disclosed
Sep 21, 2026 8-K 2 signals fired
Core
Indication Expansion Clinical Hold
Aug 6, 2026 10-Q 45 signals fired · top 15
Other
Rsu Psu Vesting Schedule Disclosed Effective Tax Rate Reconciliation Share Repurchase Activity Disclosed Unrealized Gain Loss Disclosure Fair Value Hierarchy Disclosure Financing Activities Cash Flow Disclosure Fast Track Designation Received Convertible Debt Conversion Ipo Net Proceeds Disclosure Fast Track Granted Liquidity Position Snapshot Disclosed Share Withholding Tax Settlement Convertible Notes Conversion Terms Disclosed
Core
Regulatory Designation Only
Biotech Risk
Orphan Drug Designation
Aug 6, 2026 8-K 8 signals fired
Other
Liquidity Position Snapshot Disclosed International Expansion Merger Proxy Statement Disclosure Form 8K Filing Disclosure Free Cash Flow Metric Disclosed Operating Income Year Over Year Increase
Core
Indication Expansion
Healthcare
Pricing Power Services
Aug 4, 2026 8-K 26 signals fired · top 15
Other
Corporate Authority Representation New York Jurisdiction Clause Corporate Organization And Standing Representation Sanctions Compliance Representation Amendment Modification Waiver Clause Board Committee Member Listing Hazardous Materials Definition Erisa Definition Or Compliance Statement No Broker Fees Representation Cause For Termination Defined Share Withholding Tax Settlement Change Of Control Definition Successor Agent Appointment Provision Confidential Information Return Obligation Non Assignment Clause
Aug 3, 2026 8-K 9 signals fired
Other
Merger Proxy Statement Disclosure Board Fairness Determination Director Continuity Stated Kol Endorsement Merger Acquisition Synergy Benefit Claim Geographic Footprint Disclosure Headcount Disclosure Standard
Core
Indication Expansion Clinical Hold
May 7, 2026 10-Q 52 signals fired · top 15
Other
Share Repurchase Activity Disclosed Unrealized Gain Loss Disclosure Liquidity Position Snapshot Disclosed Segment Aggregation Disclosure Share Withholding Tax Settlement Financing Activities Cash Flow Disclosure Fast Track Designation Received Priority Review Or Pdufa Disclosed Employment Termination Upon Death Severance Payment Obligation Executive Severance Change Of Control Fast Track Granted
Core
Regulatory Designation Only Management Exodus Clinical Trial Result
May 7, 2026 8-K 12 signals fired
Other
International Expansion Asset Sale Announced Fast Track Granted Priority Review Or Pdufa Disclosed Fast Track Designation Received Geographic Footprint Disclosure Operating Margin Declining Free Cash Flow Metric Disclosed
Biotech Risk
Accelerated Approval
Core
Near Term Regulatory Decision Indication Expansion Clinical Hold
May 1, 2026 8-K 8 signals fired
Other
Performance Unit Award Establishment Equity Award Plan Types Enumerated Classified Board Director Election Non Employee Director Compensation Disclosed Equity Plan Amendment Restriction Nonqualified Stock Option Exercise Or Grant Rsu Psu Vesting Schedule Disclosed Employment Termination Upon Death